QUERCETIN,

QUERCETIN, was reported 1266 times

QUERCETIN, is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL PANCREATIC ANOMALY 1 0.1111
1 CHRONIC LYMPHOCYTIC LEUKAEMIA (IN REMISSION) 1 0.1111
2 APPLICATION SITE PLAQUE 1 0.0435
3 DIABETIC AMYOTROPHY 1 0.0333
4 ARTERIAL STIFFNESS 1 0.0333
5 BLOOD ZINC DECREASED 5 0.0275
6 AQUAGENIC PRURITUS 2 0.0244
7 ALCOHOL TEST FALSE POSITIVE 2 0.0213
8 CATHETER SITE PAPULE 1 0.0185
9 INTESTINAL BARRIER DYSFUNCTION 2 0.0172
10 BURSA INJURY 1 0.0154
11 COLD AGGLUTININS POSITIVE 1 0.0143
12 HYPOBARISM 2 0.0134
13 COELIAC ARTERY COMPRESSION SYNDROME 1 0.0133
14 ALPHA 1 GLOBULIN INCREASED 1 0.0125
15 ALPHA 2 GLOBULIN INCREASED 1 0.0101
16 ALLERGY TO VACCINE 3 0.0097
17 MONONEUROPATHY 2 0.0096
18 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
19 UPPER MOTOR NEURONE LESION 2 0.0091
20 AMYLASE DECREASED 1 0.0090
21 CEREBRAL VASCULAR OCCLUSION 1 0.0087
22 COLD FLASH 1 0.0086
23 VASCULAR ACCESS SITE COMPLICATION 2 0.0079
24 BODY SURFACE AREA INCREASED 1 0.0078
25 MAST CELL ACTIVATION SYNDROME 10 0.0071
26 DIAPHRAGMATIC SPASM 1 0.0068
27 BASOSQUAMOUS CARCINOMA 1 0.0067
28 SYSTEMIC MASTOCYTOSIS 2 0.0066
29 BLOOD CHLORIDE ABNORMAL 1 0.0062
30 BASOPHIL PERCENTAGE INCREASED 1 0.0057
31 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 2 0.0056
32 DYSSOMNIA 1 0.0052
33 CATHETER SITE INDURATION 1 0.0052
34 COLD URTICARIA 1 0.0045
35 EYELID INFECTION 2 0.0045
36 EHLERS-DANLOS SYNDROME 2 0.0043
37 MASTOCYTOSIS 2 0.0042
38 AUTOPHOBIA 1 0.0039
39 GADOLINIUM DEPOSITION DISEASE 2 0.0036
40 AUTOANTIBODY POSITIVE 1 0.0036
41 DERMATILLOMANIA 2 0.0034
42 ADVERSE FOOD REACTION 3 0.0032
43 ARTHRITIS REACTIVE 2 0.0032
44 NASAL PRURITUS 4 0.0032
45 ALLERGY TO ARTHROPOD BITE 1 0.0031
46 NASAL CRUSTING 2 0.0031
47 ALOPECIA TOTALIS 1 0.0030
48 CATHETER SITE BRUISE 1 0.0030
49 COAGULATION TIME SHORTENED 1 0.0030
50 CATHETER SITE IRRITATION 1 0.0030
51 CAROTID ARTERY ANEURYSM 1 0.0029
52 WAIST CIRCUMFERENCE INCREASED 3 0.0029
53 BURNING SENSATION MUCOSAL 1 0.0028
54 TRYPTASE INCREASED 2 0.0028
55 IRON OVERLOAD 3 0.0028
56 CENTRAL OBESITY 2 0.0027
57 BONE TUBERCULOSIS 1 0.0026
58 CARDIOVASCULAR SYMPTOM 1 0.0026
59 AORTIC DISORDER 2 0.0025
60 VITAMIN B12 INCREASED 2 0.0025
61 CATHETER SITE EXTRAVASATION 1 0.0025
62 BONE DENSITY INCREASED 1 0.0025
63 LIP ERYTHEMA 2 0.0025
64 FOOD ALLERGY 19 0.0025
65 POST-ACUTE COVID-19 SYNDROME 3 0.0024
66 DYSCHROMATOPSIA 2 0.0024
67 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
68 BLOOD HOMOCYSTEINE INCREASED 1 0.0023
69 BANKRUPTCY 1 0.0022
70 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
71 OROPHARYNGEAL CANDIDIASIS 2 0.0022
72 BLOOD CHROMOGRANIN A INCREASED 1 0.0022
73 AIR EMBOLISM 1 0.0021
74 INFUSION SITE NODULE 2 0.0021
75 BLOOD URIC ACID DECREASED 1 0.0021
76 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
77 NEUROENDOCRINE CARCINOMA OF THE SKIN 2 0.0020
78 PRECANCEROUS SKIN LESION 3 0.0020
79 DRAINAGE 1 0.0020
80 ANAEMIA VITAMIN B12 DEFICIENCY 1 0.0020
81 BRAIN NEOPLASM BENIGN 1 0.0020
82 STEROID WITHDRAWAL SYNDROME 2 0.0020
83 LIGHT CHAIN ANALYSIS INCREASED 2 0.0019
84 VASCULAR CALCIFICATION 2 0.0019
85 AUTOSCOPY 1 0.0019
86 COLLAGEN DISORDER 1 0.0017
87 BLOOD OESTROGEN INCREASED 1 0.0017
88 HYPERTENSIVE EMERGENCY 2 0.0017
89 STERNAL FRACTURE 2 0.0016
90 NEPHRITIS INTERSTITIAL 2 0.0016
91 CHALAZION 1 0.0016
92 BLADDER IRRITATION 1 0.0016
93 SLOW RESPONSE TO STIMULI 2 0.0015
94 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
95 CELLULITIS STAPHYLOCOCCAL 1 0.0015
96 JOINT NOISE 3 0.0015
97 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
98 COMPULSIONS 1 0.0015
99 INFUSION SITE RASH 2 0.0015
100 ARACHNOIDITIS 1 0.0014
101 EAR PRURITUS 5 0.0014
102 AUDITORY DISORDER 2 0.0014
103 DISSOCIATIVE DISORDER 1 0.0014
104 ATROPHIC VULVOVAGINITIS 1 0.0014
105 CYCLIC VOMITING SYNDROME 1 0.0014
106 CATHETER SITE RELATED REACTION 1 0.0013
107 ORAL MUCOSAL EXFOLIATION 2 0.0013
108 ALLERGIC COUGH 1 0.0013
109 BLISTER INFECTED 1 0.0013
110 CONTRAST MEDIA REACTION 3 0.0013
111 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
112 PERIORBITAL SWELLING 7 0.0012
113 BREAST OPERATION 1 0.0012
114 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
115 SEBORRHOEIC DERMATITIS 2 0.0012
116 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
117 DEPERSONALISATION 1 0.0012
118 ADRENAL SUPPRESSION 1 0.0012
119 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
120 INFUSION SITE DISCHARGE 2 0.0011
121 CEREBELLAR ATROPHY 1 0.0011
122 PANCREATIC FAILURE 2 0.0011
123 BLOOD MAGNESIUM INCREASED 1 0.0011
124 OBSESSIVE THOUGHTS 2 0.0011
125 ESSENTIAL HYPERTENSION 2 0.0011
126 IMPATIENCE 2 0.0011
127 TENDON PAIN 8 0.0011
128 UPPER RESPIRATORY TRACT CONGESTION 3 0.0010
129 EARLY SATIETY 2 0.0010
130 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
131 BRAIN FOG 16 0.0010
132 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
133 AUTONOMIC NEUROPATHY 1 0.0010
134 MUSCLE CONTRACTURE 2 0.0010
135 EYELID PAIN 2 0.0010
136 ARTHRODESIS 1 0.0010
137 BREAST DISCOMFORT 1 0.0010
138 EYELIDS PRURITUS 3 0.0010
139 CYTOGENETIC ANALYSIS ABNORMAL 1 0.0010
140 NON-CARDIAC CHEST PAIN 3 0.0009
141 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
142 INFUSION SITE BRUISING 2 0.0009
143 LYMPHOCYTE COUNT INCREASED 3 0.0009
144 TEMPERATURE REGULATION DISORDER 2 0.0009
145 PRODUCT PACKAGE ASSOCIATED INJURY 2 0.0009
146 TEMPERATURE INTOLERANCE 9 0.0009
147 CHEMICAL BURN 1 0.0009
148 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
149 SINUS PAIN 2 0.0009
150 SEASONAL ALLERGY 12 0.0008
151 SKIN FRAGILITY 2 0.0008
152 FOOD INTOLERANCE 3 0.0008
153 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
154 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
155 AMPUTATION 1 0.0008
156 PRE-EXISTING CONDITION IMPROVED 5 0.0008
157 THROAT CLEARING 3 0.0008
158 AORTIC VALVE REPLACEMENT 1 0.0008
159 EYELID IRRITATION 2 0.0008
160 INFUSION SITE SWELLING 5 0.0008
161 LIPOMA 2 0.0008
162 ADJUSTMENT DISORDER 1 0.0008
163 ABDOMINAL OPERATION 1 0.0008
164 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
165 MULTIPLE ALLERGIES 6 0.0008
166 SKIN ODOUR ABNORMAL 3 0.0008
167 INCREASED TENDENCY TO BRUISE 7 0.0008
168 LUNG OPACITY 2 0.0008
169 RADICULOPATHY 2 0.0008
170 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
171 ANION GAP INCREASED 1 0.0007
172 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
173 EAR CONGESTION 2 0.0007
174 LIP BLISTER 2 0.0007
175 CALCULUS BLADDER 1 0.0007
176 AGORAPHOBIA 1 0.0007
177 CORNEAL ABRASION 1 0.0007
178 ECCHYMOSIS 5 0.0007
179 RHINALGIA 2 0.0007
180 SPINAL STENOSIS 3 0.0007
181 EOSINOPHILIC OESOPHAGITIS 2 0.0007
182 CONNECTIVE TISSUE DISORDER 1 0.0007
183 TENSION HEADACHE 3 0.0007
184 TEARFULNESS 3 0.0007
185 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
186 VITAMIN B12 DECREASED 2 0.0007
187 HYPERVENTILATION 4 0.0007
188 TOOTH DISCOLOURATION 2 0.0007
189 COCCYDYNIA 1 0.0007
190 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
191 FEELING DRUNK 5 0.0007
192 INFUSION SITE REACTION 2 0.0007
193 ASTIGMATISM 1 0.0007
194 SYNOVIAL CYST 3 0.0006
195 DAYDREAMING 1 0.0006
196 SKIN LACERATION 7 0.0006
197 BLOOD BLISTER 2 0.0006
198 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
199 SKIN ABRASION 3 0.0006
200 COLITIS MICROSCOPIC 3 0.0006
201 PHOTOPSIA 4 0.0006
202 MUSCLE ATROPHY 8 0.0006
203 CYSTITIS INTERSTITIAL 1 0.0006
204 DISINHIBITION 1 0.0006
205 ANAPHYLACTIC SHOCK 16 0.0006
206 FRUSTRATION TOLERANCE DECREASED 5 0.0006
207 HORMONE LEVEL ABNORMAL 3 0.0006
208 COSTOCHONDRITIS 1 0.0006
209 MICTURITION URGENCY 7 0.0006
210 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
211 PLANTAR FASCIITIS 2 0.0006
212 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
213 DEAFNESS BILATERAL 1 0.0006
214 BLOOD MAGNESIUM DECREASED 5 0.0006
215 MALABSORPTION 3 0.0006
216 HAEMORRHAGIC DIATHESIS 2 0.0006
217 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
218 ROTATOR CUFF SYNDROME 7 0.0005
219 BODY TEMPERATURE ABNORMAL 1 0.0005
220 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
221 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
222 DENTAL CARE 1 0.0005
223 NERVE INJURY 6 0.0005
224 INTRACRANIAL PRESSURE INCREASED 3 0.0005
225 HEART RATE ABNORMAL 3 0.0005
226 TENDON INJURY 2 0.0005
227 HYPERACUSIS 2 0.0005
228 NEURALGIA 13 0.0005
229 IMMUNE SYSTEM DISORDER 7 0.0005
230 PARANASAL SINUS DISCOMFORT 2 0.0005
231 FACE INJURY 2 0.0005
232 ARTERIAL DISORDER 1 0.0005
233 SKIN ATROPHY 3 0.0005
234 SINUS CONGESTION 7 0.0005
235 CONVERSION DISORDER 1 0.0005
236 THERAPY PARTIAL RESPONDER 8 0.0005
237 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
238 SPINAL PAIN 6 0.0005
239 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
240 PHARYNGEAL SWELLING 5 0.0005
241 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 28 0.0005
242 OESOPHAGEAL PAIN 2 0.0005
243 SINUS HEADACHE 3 0.0005
244 NASAL DISCOMFORT 4 0.0005
245 BLADDER DISORDER 5 0.0005
246 BLOOD PRESSURE ABNORMAL 10 0.0005
247 HYPERPHAGIA 2 0.0005
248 FUNGAL SKIN INFECTION 2 0.0005
249 INFUSION SITE EXTRAVASATION 3 0.0005
250 BODY TEMPERATURE FLUCTUATION 1 0.0005
251 SWELLING OF EYELID 3 0.0005
252 SLEEP TERROR 2 0.0005
253 DEVICE CONNECTION ISSUE 1 0.0005
254 HEREDITARY ANGIOEDEMA 5 0.0005
255 DEREALISATION 1 0.0005
256 TONGUE DISCOLOURATION 2 0.0005
257 ONYCHOMYCOSIS 2 0.0005
258 DYSGRAPHIA 3 0.0005
259 WHEELCHAIR USER 2 0.0004
260 OCULAR DISCOMFORT 5 0.0004
261 BRONCHIECTASIS 3 0.0004
262 AGEUSIA 11 0.0004
263 EAR DISORDER 2 0.0004
264 SENSORY DISTURBANCE 7 0.0004
265 BREAKTHROUGH PAIN 1 0.0004
266 ANGIOEDEMA 19 0.0004
267 BILIRUBIN CONJUGATED INCREASED 1 0.0004
268 DISCOURAGEMENT 1 0.0004
269 TIBIA FRACTURE 2 0.0004
270 SKIN TIGHTNESS 2 0.0004
271 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
272 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
273 INTENTIONAL DOSE OMISSION 12 0.0004
274 EYE INFLAMMATION 4 0.0004
275 RASH VESICULAR 2 0.0004
276 DERMAL CYST 1 0.0004
277 VITREOUS FLOATERS 4 0.0004
278 NASAL POLYPS 2 0.0004
279 DEVICE INFUSION ISSUE 1 0.0004
280 OVARIAN CYST 4 0.0004
281 VEIN DISORDER 2 0.0004
282 HEAD DISCOMFORT 7 0.0004
283 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
284 DRY THROAT 4 0.0004
285 APPENDICITIS PERFORATED 1 0.0004
286 DISSOCIATION 3 0.0004
287 MUSCLE TWITCHING 9 0.0004
288 EAR DISCOMFORT 4 0.0004
289 INFUSION SITE PAIN 5 0.0004
290 MUSCULOSKELETAL CHEST PAIN 6 0.0004
291 ACTINIC KERATOSIS 1 0.0004
292 FAILURE TO THRIVE 2 0.0004
293 PANIC ATTACK 14 0.0004
294 PLATELET COUNT INCREASED 5 0.0004
295 WEIGHT FLUCTUATION 4 0.0004
296 PARTIAL SEIZURES 2 0.0004
297 GINGIVAL PAIN 3 0.0004
298 MOOD SWINGS 12 0.0004
299 AREFLEXIA 1 0.0004
300 FOOD POISONING 2 0.0004
301 ABDOMINAL MASS 1 0.0004
302 THROAT TIGHTNESS 10 0.0004
303 ERYTHEMA OF EYELID 2 0.0004
304 ABDOMINAL RIGIDITY 1 0.0004
305 CLUMSINESS 1 0.0004
306 ABNORMAL FAECES 3 0.0004
307 CLONUS 1 0.0004
308 PERIPHERAL COLDNESS 5 0.0004
309 HYPERKERATOSIS 2 0.0004
310 STREPTOCOCCAL INFECTION 2 0.0004
311 COORDINATION ABNORMAL 5 0.0004
312 SNEEZING 8 0.0004
313 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
314 FACIAL PARALYSIS 3 0.0004
315 IMPAIRED DRIVING ABILITY 4 0.0004
316 DERMATITIS CONTACT 4 0.0004
317 NEUROLOGICAL SYMPTOM 2 0.0003
318 MOUTH SWELLING 2 0.0003
319 HYSTERECTOMY 3 0.0003
320 SKIN WARM 2 0.0003
321 COGNITIVE DISORDER 16 0.0003
322 SPLENOMEGALY 4 0.0003
323 URINE ODOUR ABNORMAL 2 0.0003
324 PURPURA 3 0.0003
325 SKIN HAEMORRHAGE 5 0.0003
326 IMMUNODEFICIENCY 5 0.0003
327 MACULAR DEGENERATION 4 0.0003
328 SYMPTOM RECURRENCE 2 0.0003
329 WRIST FRACTURE 4 0.0003
330 HEAVY MENSTRUAL BLEEDING 3 0.0003
331 TOOTHACHE 6 0.0003
332 CRANIOCEREBRAL INJURY 1 0.0003
333 INSURANCE ISSUE 5 0.0003
334 TINNITUS 15 0.0003
335 MENISCUS INJURY 2 0.0003
336 TENDON RUPTURE 4 0.0003
337 DIASTOLIC DYSFUNCTION 1 0.0003
338 TENDONITIS 5 0.0003
339 OLIGURIA 2 0.0003
340 THINKING ABNORMAL 6 0.0003
341 SECRETION DISCHARGE 4 0.0003
342 PHOTOPHOBIA 6 0.0003
343 SQUAMOUS CELL CARCINOMA 3 0.0003
344 HOT FLUSH 24 0.0003
345 DRUG EFFECT INCREASED 1 0.0003
346 THERAPEUTIC RESPONSE CHANGED 2 0.0003
347 BLADDER PAIN 1 0.0003
348 FEELING JITTERY 6 0.0003
349 FOREIGN BODY SENSATION IN EYES 2 0.0003
350 EYE IRRITATION 18 0.0003
351 CARDIAC FLUTTER 2 0.0003
352 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
353 BONE PAIN 18 0.0003
354 BACTERIAL SEPSIS 1 0.0003
355 SKIN FISSURES 6 0.0003
356 COELIAC DISEASE 3 0.0003
357 THERAPY CHANGE 3 0.0003
358 ORAL CANDIDIASIS 4 0.0003
359 HOSPICE CARE 3 0.0003
360 PRODUCT FORMULATION ISSUE 2 0.0003
361 COVID-19 53 0.0003
362 EYE PAIN 17 0.0003
363 CONTUSION 29 0.0003
364 MENINGITIS 2 0.0003
365 POST-TRAUMATIC STRESS DISORDER 2 0.0003
366 FULL BLOOD COUNT DECREASED 6 0.0003
367 PRODUCT PHYSICAL ISSUE 6 0.0003
368 CLOSTRIDIAL INFECTION 1 0.0003
369 DISEASE RECURRENCE 14 0.0003
370 SLUGGISHNESS 3 0.0003
371 IMPAIRED GASTRIC EMPTYING 4 0.0003
372 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
373 AKATHISIA 4 0.0003
374 BLOOD TESTOSTERONE DECREASED 2 0.0003
375 EYE MOVEMENT DISORDER 2 0.0003
376 SKIN LESION 8 0.0003
377 LIMB DISCOMFORT 9 0.0003
378 APLASIA PURE RED CELL 1 0.0003
379 MUSCULOSKELETAL DISCOMFORT 5 0.0003
380 RESPIRATION ABNORMAL 2 0.0003
381 CERVICAL VERTEBRAL FRACTURE 1 0.0003
382 AORTIC STENOSIS 1 0.0003
383 MASS 4 0.0003
384 CYSTITIS 9 0.0003
385 HYPOTHYROIDISM 9 0.0003
386 DRY EYE 14 0.0003
387 FEAR OF INJECTION 2 0.0003
388 POOR QUALITY SLEEP 6 0.0003
389 IMPAIRED QUALITY OF LIFE 4 0.0003
390 GASTROENTERITIS VIRAL 5 0.0003
391 DEVICE KINK 1 0.0003
392 GASTROINTESTINAL PAIN 3 0.0003
393 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
394 SENSITIVE SKIN 2 0.0003
395 PSYCHOTIC DISORDER 8 0.0003
396 URINARY INCONTINENCE 8 0.0003
397 WHEEZING 16 0.0003
398 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
399 THROAT IRRITATION 12 0.0003
400 SKIN INFECTION 3 0.0003
401 BLOOD CALCIUM DECREASED 3 0.0003
402 BLOOD SODIUM DECREASED 5 0.0003
403 PAROSMIA 2 0.0003
404 LACRIMATION INCREASED 8 0.0003
405 AUTOIMMUNE THYROIDITIS 1 0.0003
406 TROPONIN INCREASED 2 0.0003
407 INTERNAL HAEMORRHAGE 3 0.0003
408 COMMUNICATION DISORDER 1 0.0003
409 PARAESTHESIA 41 0.0003
410 METASTASES TO LUNG 3 0.0003
411 RASH MACULAR 9 0.0003
412 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
413 AFFECTIVE DISORDER 2 0.0003
414 PRODUCT USE COMPLAINT 4 0.0003
415 DIVERTICULITIS 7 0.0003
416 BLOOD ALBUMIN DECREASED 2 0.0003
417 NOCTURIA 3 0.0002
418 MUSCLE DISORDER 2 0.0002
419 FEEDING DISORDER 5 0.0002
420 MUSCULAR WEAKNESS 28 0.0002
421 BACK DISORDER 4 0.0002
422 SWELLING FACE 16 0.0002
423 HYPERAESTHESIA 2 0.0002
424 PHOTOSENSITIVITY REACTION 4 0.0002
425 DISTURBANCE IN ATTENTION 13 0.0002
426 PERIPHERAL SWELLING 37 0.0002
427 NASAL CONGESTION 14 0.0002
428 HAEMODIALYSIS 2 0.0002
429 EYE PRURITUS 8 0.0002
430 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
431 HALLUCINATION, VISUAL 5 0.0002
432 FATIGUE 183 0.0002
433 AORTIC VALVE INCOMPETENCE 1 0.0002
434 IMPAIRED WORK ABILITY 5 0.0002
435 PRODUCT CONTAINER ISSUE 2 0.0002
436 ILLNESS 24 0.0002
437 BALANCE DISORDER 20 0.0002
438 NEUROPATHY PERIPHERAL 22 0.0002
439 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
440 SKIN SWELLING 2 0.0002
441 CHAPPED LIPS 1 0.0002
442 FLATULENCE 13 0.0002
443 NAIL DISORDER 2 0.0002
444 SYRINGE ISSUE 4 0.0002
445 DYSPHEMIA 1 0.0002
446 DERMATITIS ATOPIC 12 0.0002
447 SARS-COV-2 TEST POSITIVE 3 0.0002
448 SLEEP DISORDER 16 0.0002
449 ABDOMINAL ABSCESS 1 0.0002
450 BLOOD CREATINE INCREASED 1 0.0002
451 SINUSITIS 23 0.0002
452 GALLBLADDER DISORDER 4 0.0002
453 FACIAL PAIN 2 0.0002
454 THIRST 4 0.0002
455 QUALITY OF LIFE DECREASED 3 0.0002
456 GASTROINTESTINAL INFECTION 2 0.0002
457 HEART RATE IRREGULAR 5 0.0002
458 LIP DRY 2 0.0002
459 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
460 MOOD ALTERED 6 0.0002
461 RESTLESS LEGS SYNDROME 4 0.0002
462 PRODUCT AVAILABILITY ISSUE 5 0.0002
463 DISEASE COMPLICATION 1 0.0002
464 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
465 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
466 ANAPHYLACTIC REACTION 12 0.0002
467 RHINORRHOEA 14 0.0002
468 PROCEDURAL PAIN 6 0.0002
469 ORAL DISCOMFORT 3 0.0002
470 PRODUCT DISTRIBUTION ISSUE 2 0.0002
471 FEELING COLD 6 0.0002
472 PERSONALITY CHANGE 2 0.0002
473 EYE SWELLING 8 0.0002
474 BURNING SENSATION 15 0.0002
475 FLANK PAIN 2 0.0002
476 SPINAL DISORDER 2 0.0002
477 ABDOMINAL DISTENSION 22 0.0002
478 HYPERSENSITIVITY 39 0.0002
479 RED BLOOD CELL COUNT DECREASED 6 0.0002
480 MIGRAINE 20 0.0002
481 HYPERSOMNIA 6 0.0002
482 URTICARIA 35 0.0002
483 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
484 PARAESTHESIA ORAL 3 0.0002
485 ANOSMIA 3 0.0002
486 HYPERTHYROIDISM 3 0.0002
487 ANGER 7 0.0002
488 DIZZINESS POSTURAL 2 0.0002
489 AUTOIMMUNE DISORDER 2 0.0002
490 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
491 VITAMIN D DEFICIENCY 2 0.0002
492 SWELLING 19 0.0002
493 APPLICATION SITE BURN 1 0.0002
494 RASH PRURITIC 11 0.0002
495 OEDEMA 11 0.0002
496 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
497 LIGAMENT SPRAIN 2 0.0002
498 DISORIENTATION 8 0.0002
499 HAEMATOCRIT DECREASED 4 0.0002
500 INABILITY TO AFFORD MEDICATION 2 0.0002
501 ABDOMINAL TENDERNESS 1 0.0002
502 HYPOTONIA 2 0.0002
503 AMNESIA 13 0.0002
504 HEART RATE DECREASED 7 0.0002
505 HYPOAESTHESIA ORAL 3 0.0002
506 LYMPHADENOPATHY 7 0.0002
507 DRUG TOLERANCE 1 0.0002
508 DYSPHORIA 1 0.0002
509 ABDOMINAL DISCOMFORT 33 0.0002
510 NEUTROPHIL COUNT INCREASED 2 0.0002
511 INITIAL INSOMNIA 2 0.0002
512 THYROID DISORDER 3 0.0002
513 INFLUENZA LIKE ILLNESS 16 0.0002
514 FEMUR FRACTURE 6 0.0002
515 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
516 CRYING 7 0.0002
517 EYE DISCHARGE 2 0.0002
518 PULMONARY HYPERTENSION 4 0.0002
519 TENDERNESS 2 0.0002
520 HEART RATE INCREASED 19 0.0002
521 DEAFNESS 5 0.0002
522 ECZEMA 10 0.0002
523 INCONTINENCE 2 0.0002
524 MYALGIA 32 0.0002
525 DYSPHONIA 11 0.0002
526 EAR INFECTION 5 0.0002
527 JOINT INJURY 4 0.0002
528 FLUSHING 19 0.0002
529 COMPRESSION FRACTURE 1 0.0002
530 HIP FRACTURE 6 0.0002
531 IRRITABLE BOWEL SYNDROME 4 0.0002
532 FEAR 5 0.0002
533 BRUXISM 1 0.0002
534 MUSCLE TIGHTNESS 3 0.0002
535 LUNG DISORDER 9 0.0002
536 PRODUCT PRESCRIBING ISSUE 4 0.0002
537 ANXIETY 52 0.0002
538 BLOOD GLUCOSE FLUCTUATION 2 0.0002
539 COUGH 51 0.0002
540 INJECTION SITE NODULE 2 0.0002
541 DEAFNESS UNILATERAL 1 0.0002
542 TOOTH FRACTURE 2 0.0002
543 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
544 DENTAL CARIES 2 0.0002
545 TREMOR 30 0.0002
546 LIP SWELLING 6 0.0002
547 GAIT INABILITY 6 0.0002
548 PALPITATIONS 21 0.0002
549 NECK PAIN 10 0.0002
550 DEMENTIA 5 0.0002
551 MALNUTRITION 2 0.0002
552 PLATELET COUNT DECREASED 19 0.0002
553 ARTHRITIS 14 0.0002
554 CANDIDA INFECTION 3 0.0002
555 PRURITUS 68 0.0002
556 MITRAL VALVE INCOMPETENCE 2 0.0002
557 CHOLECYSTITIS ACUTE 1 0.0002
558 INSOMNIA 47 0.0002
559 THERAPY CESSATION 9 0.0002
560 CHOLECYSTECTOMY 2 0.0002
561 HERPES ZOSTER 10 0.0002
562 PRODUCT DOSE OMISSION ISSUE 51 0.0002
563 BLOOD URIC ACID INCREASED 1 0.0002
564 ARTHRALGIA 72 0.0002
565 ALOPECIA 34 0.0002
566 ELECTROLYTE IMBALANCE 2 0.0002
567 EYELID OEDEMA 2 0.0002
568 MUSCULOSKELETAL PAIN 9 0.0002
569 DYSSTASIA 5 0.0002
570 FEELING ABNORMAL 41 0.0002
571 METASTASES TO LIVER 3 0.0002
572 INFLUENZA 19 0.0002
573 LYMPHOCYTE COUNT DECREASED 3 0.0002
574 CONSTIPATION 37 0.0002
575 VISUAL IMPAIRMENT 21 0.0002
576 LABORATORY TEST ABNORMAL 5 0.0002
577 BRADYKINESIA 1 0.0002
578 MUSCLE SPASMS 31 0.0002
579 BLOOD IRON DECREASED 2 0.0002
580 ATAXIA 2 0.0002
581 POLLAKIURIA 7 0.0002
582 GASTROINTESTINAL DISORDER 15 0.0002
583 HYPERLIPIDAEMIA 2 0.0002
584 POLYNEUROPATHY 2 0.0002
585 ADVERSE DRUG REACTION 15 0.0002
586 WITHDRAWAL SYNDROME 7 0.0002
587 BLOOD PRESSURE FLUCTUATION 4 0.0002
588 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
589 STOMATITIS 10 0.0002
590 FIBROMYALGIA 4 0.0002
591 PRESYNCOPE 4 0.0002
592 DERMATITIS ACNEIFORM 1 0.0002
593 VERTIGO 10 0.0002
594 SUICIDAL IDEATION 15 0.0002
595 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
596 SPINAL OPERATION 2 0.0002
597 OROPHARYNGEAL PAIN 15 0.0002
598 GENERALISED OEDEMA 2 0.0002
599 DYSGEUSIA 12 0.0002
600 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
601 HAIR COLOUR CHANGES 2 0.0002
602 VISION BLURRED 22 0.0002
603 OXYGEN SATURATION DECREASED 9 0.0002
604 SWOLLEN TONGUE 5 0.0002
605 MUSCULOSKELETAL STIFFNESS 14 0.0002
606 DERMATITIS ALLERGIC 2 0.0002
607 BLEPHAROSPASM 1 0.0002
608 SLEEP APNOEA SYNDROME 3 0.0002
609 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
610 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
611 DIZZINESS 78 0.0002
612 HEADACHE 98 0.0002
613 NIGHT SWEATS 5 0.0002
614 PRESCRIBED OVERDOSE 3 0.0002
615 HAEMATOMA 4 0.0002
616 EXPOSURE VIA SKIN CONTACT 4 0.0002
617 EAR PAIN 3 0.0002
618 SKIN EXFOLIATION 13 0.0002
619 CHOKING 3 0.0002
620 HYPOAESTHESIA 23 0.0002
621 BRADYPHRENIA 1 0.0002
622 BEDRIDDEN 2 0.0002
623 EYE DISORDER 5 0.0002
624 INFECTION 22 0.0002
625 WEIGHT INCREASED 34 0.0002
626 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
627 CORONAVIRUS INFECTION 1 0.0002
628 APPETITE DISORDER 1 0.0002
629 ADVERSE REACTION 2 0.0002
630 BLOOD CHOLESTEROL INCREASED 7 0.0002
631 IRRITABILITY 9 0.0001
632 HAIR TEXTURE ABNORMAL 2 0.0001
633 MALIGNANT MELANOMA 2 0.0001
634 JOINT SWELLING 18 0.0001
635 TASTE DISORDER 3 0.0001
636 LIMB INJURY 4 0.0001
637 TACHYPNOEA 2 0.0001
638 PRODUCTIVE COUGH 7 0.0001
639 CHEST DISCOMFORT 15 0.0001
640 NASOPHARYNGITIS 27 0.0001
641 RASH ERYTHEMATOUS 7 0.0001
642 PAIN IN EXTREMITY 43 0.0001
643 CHILLS 17 0.0001
644 ABNORMAL DREAMS 4 0.0001
645 APHONIA 2 0.0001
646 DEFAECATION URGENCY 1 0.0001
647 HYPERKALAEMIA 5 0.0001
648 BLISTER 8 0.0001
649 MOUTH ULCERATION 3 0.0001
650 HYPOXIA 5 0.0001
651 DUODENAL ULCER 1 0.0001
652 LYMPHOPENIA 2 0.0001
653 PAIN IN JAW 4 0.0001
654 EATING DISORDER 3 0.0001
655 DIVERTICULUM 1 0.0001
656 BRONCHOSPASM 2 0.0001
657 LIVER FUNCTION TEST INCREASED 3 0.0001
658 HYPERHIDROSIS 18 0.0001
659 PRODUCT SUBSTITUTION ISSUE 8 0.0001
660 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
661 ASTHENIA 52 0.0001
662 MEMORY IMPAIRMENT 19 0.0001
663 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
664 APATHY 2 0.0001
665 DEPRESSION 31 0.0001
666 ASCITES 4 0.0001
667 BLINDNESS TRANSIENT 1 0.0001
668 BRONCHITIS 10 0.0001
669 ARTHROPOD BITE 1 0.0001
670 PULMONARY MASS 2 0.0001
671 PRODUCT USE IN UNAPPROVED INDICATION 33 0.0001
672 CHROMATURIA 3 0.0001
673 BREAST TENDERNESS 1 0.0001
674 APHASIA 4 0.0001
675 DEPRESSED MOOD 7 0.0001
676 DYSPEPSIA 13 0.0001
677 DISCOMFORT 8 0.0001
678 FEELING HOT 8 0.0001
679 DIARRHOEA 84 0.0001
680 CONCUSSION 1 0.0001
681 SOMNOLENCE 26 0.0001
682 APHTHOUS ULCER 1 0.0001
683 PRODUCT USE ISSUE 24 0.0001
684 HAEMATOCHEZIA 7 0.0001
685 DYSPHAGIA 12 0.0001
686 HEAD INJURY 4 0.0001
687 HALLUCINATION, AUDITORY 2 0.0001
688 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
689 RASH 54 0.0001
690 MENTAL IMPAIRMENT 3 0.0001
691 DYSPNOEA 70 0.0001
692 INJECTION SITE URTICARIA 3 0.0001
693 LIVER INJURY 3 0.0001
694 IMPAIRED HEALING 4 0.0001
695 MANIA 2 0.0001
696 ABASIA 3 0.0001
697 STAPHYLOCOCCAL INFECTION 4 0.0001
698 EPISTAXIS 9 0.0001
699 VIRAL INFECTION 4 0.0001
700 SKIN DISORDER 4 0.0001
701 URINARY RETENTION 4 0.0001
702 CELLULITIS 6 0.0001
703 INJECTION SITE SWELLING 9 0.0001
704 HEPATIC ENZYME INCREASED 8 0.0001
705 LOSS OF CONSCIOUSNESS 15 0.0001
706 SCAR 2 0.0001
707 CARDIAC OPERATION 1 0.0001
708 HYPOACUSIS 5 0.0001
709 ABDOMINAL PAIN 27 0.0001
710 CARDIAC MURMUR 1 0.0001
711 CONDITION AGGRAVATED 35 0.0001
712 NEOPLASM PROGRESSION 4 0.0001
713 ASTHMA 13 0.0001
714 MENTAL DISORDER 5 0.0001
715 ORTHOSTATIC HYPOTENSION 2 0.0001
716 SPEECH DISORDER 6 0.0001
717 COLD SWEAT 2 0.0001
718 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
719 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
720 DRY SKIN 15 0.0001
721 MENSTRUATION IRREGULAR 3 0.0001
722 DECREASED APPETITE 26 0.0001
723 THERAPY INTERRUPTED 8 0.0001
724 ERYTHEMA 23 0.0001
725 THROMBOSIS 9 0.0001
726 SKIN BURNING SENSATION 8 0.0001
727 GOUT 2 0.0001
728 ANAL INCONTINENCE 1 0.0001
729 FREQUENT BOWEL MOVEMENTS 3 0.0001
730 WEIGHT DECREASED 31 0.0001
731 DRY MOUTH 9 0.0001
732 ACCIDENTAL OVERDOSE 4 0.0001
733 BRAIN NEOPLASM 1 0.0001
734 INJECTION SITE MASS 4 0.0001
735 MENTAL STATUS CHANGES 3 0.0001
736 NAUSEA 85 0.0001
737 HEPATIC STEATOSIS 2 0.0001
738 APPENDICITIS 1 0.0001
739 DIARRHOEA HAEMORRHAGIC 1 0.0001
740 OEDEMA PERIPHERAL 13 0.0001
741 UNEVALUABLE EVENT 8 0.0001
742 INFUSION RELATED REACTION 7 0.0001
743 FOOT FRACTURE 2 0.0001
744 CONFUSIONAL STATE 17 0.0001
745 INCORRECT DOSE ADMINISTERED 24 0.0001
746 MUSCULOSKELETAL DISORDER 2 0.0001
747 INCREASED APPETITE 2 0.0001
748 BLOOD PRESSURE INCREASED 16 0.0001
749 INJECTION SITE PRURITUS 7 0.0001
750 GAIT DISTURBANCE 20 0.0001
751 LETHARGY 6 0.0001
752 PULMONARY FIBROSIS 2 0.0001
753 PAIN 64 0.0001
754 POST PROCEDURAL COMPLICATION 2 0.0001
755 LOWER LIMB FRACTURE 2 0.0001
756 ACUTE RESPIRATORY FAILURE 2 0.0001
757 HERNIA 2 0.0001
758 HYPOGLYCAEMIA 5 0.0001
759 INTENTIONAL PRODUCT MISUSE 9 0.0001
760 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
761 ORAL HERPES 2 0.0001
762 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
763 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
764 KIDNEY INFECTION 2 0.0001
765 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
766 BODY TEMPERATURE DECREASED 1 0.0001
767 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
768 SINUS DISORDER 2 0.0001
769 CATARACT 6 0.0001
770 RESPIRATORY DISORDER 3 0.0001
771 INJECTION SITE HAEMORRHAGE 8 0.0001
772 SYNCOPE 10 0.0001
773 BLOOD POTASSIUM DECREASED 3 0.0001
774 BRAIN INJURY 1 0.0001
775 BACK PAIN 23 0.0001
776 THERAPEUTIC RESPONSE DECREASED 6 0.0001
777 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
778 DRUG LEVEL DECREASED 1 0.0001
779 INJECTION SITE RASH 3 0.0001
780 HAEMOGLOBIN DECREASED 10 0.0001
781 NERVOUS SYSTEM DISORDER 3 0.0001
782 OFF LABEL USE 84 0.0001
783 ROAD TRAFFIC ACCIDENT 4 0.0001
784 DERMATITIS 2 0.0001
785 METABOLIC ACIDOSIS 3 0.0001
786 RETCHING 2 0.0001
787 BREAST PAIN 1 0.0001
788 BODY HEIGHT DECREASED 1 0.0001
789 MALAISE 41 0.0001
790 MOVEMENT DISORDER 3 0.0001
791 DRUG INTOLERANCE 9 0.0001
792 FALL 31 0.0001
793 SKIN CANCER 2 0.0001
794 PRURITUS GENERALISED 2 0.0001
795 FAECES DISCOLOURED 2 0.0001
796 BLOOD CREATININE INCREASED 6 0.0001
797 PRODUCT DISPENSING ERROR 2 0.0001
798 DIABETES MELLITUS 7 0.0001
799 EXPIRED PRODUCT ADMINISTERED 3 0.0001
800 TACHYCARDIA 8 0.0001
801 DEHYDRATION 12 0.0001
802 TRANSAMINASES INCREASED 2 0.0001
803 ORAL PAIN 2 0.0001
804 RASH PAPULAR 2 0.0001
805 THERAPY NON-RESPONDER 4 0.0001
806 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
807 APPLICATION SITE PRURITUS 2 0.0001
808 INJECTION SITE PAIN 27 0.0001
809 URINARY TRACT INFECTION 15 0.0001
810 INJECTION SITE BRUISING 7 0.0001
811 ABDOMINAL PAIN UPPER 18 0.0001
812 SKIN DISCOLOURATION 4 0.0001
813 NIGHTMARE 3 0.0001
814 DELIRIUM 3 0.0001
815 RENAL DISORDER 4 0.0001
816 SURGERY 5 0.0001
817 VOMITING 40 0.0001
818 COVID-19 PNEUMONIA 1 0.0001
819 DISEASE PROGRESSION 10 0.0001
820 OCULAR HYPERAEMIA 4 0.0001
821 PRODUCT PRESCRIBING ERROR 2 0.0001
822 PYREXIA 29 0.0001
823 LOCALISED INFECTION 2 0.0001
824 BURSITIS 1 0.0001
825 ADRENAL INSUFFICIENCY 1 0.0001
826 CYTOPENIA 1 0.0001
827 ABNORMAL WEIGHT GAIN 1 0.0001
828 PNEUMONIA ASPIRATION 2 0.0001
829 DYSPNOEA EXERTIONAL 3 0.0001
830 BRAIN OEDEMA 1 0.0001
831 ABDOMINAL PAIN LOWER 2 0.0001
832 PRODUCT COMPLAINT 2 0.0001
833 CARDIOVASCULAR DISORDER 2 0.0001
834 FLUID RETENTION 4 0.0001
835 HEPATITIS 2 0.0001
836 ERECTILE DYSFUNCTION 2 0.0001
837 DRUG RESISTANCE 2 0.0001
838 INFLAMMATION 4 0.0001
839 UNRESPONSIVE TO STIMULI 2 0.0001
840 RASH GENERALISED 2 0.0001
841 DIPLOPIA 2 0.0001
842 PRODUCT DOSE OMISSION 5 0.0001
843 NERVOUSNESS 4 0.0001
844 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
845 CHEST PAIN 14 0.0001
846 DYSMENORRHOEA 1 0.0001
847 BLOOD PRESSURE DECREASED 5 0.0001
848 HYPOTENSION 15 0.0001
849 PAIN OF SKIN 2 0.0001
850 DRUG INEFFECTIVE 97 0.0001
851 ANAEMIA 14 0.0001
852 OSTEOPOROSIS 3 0.0001
853 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
854 INJECTION SITE ERYTHEMA 9 0.0001
855 RESPIRATORY DISTRESS 2 0.0001
856 RHABDOMYOLYSIS 3 0.0001
857 ATRIAL FIBRILLATION 7 0.0001
858 HAEMOPTYSIS 2 0.0001
859 CARPAL TUNNEL SYNDROME 1 0.0001
860 BLINDNESS UNILATERAL 1 0.0001
861 OSTEOARTHRITIS 3 0.0001
862 ANGINA PECTORIS 2 0.0001
863 SEIZURE 8 0.0001
864 VAGINAL HAEMORRHAGE 3 0.0001
865 AGITATION 5 0.0001
866 CARDIOMYOPATHY 1 0.0001
867 COLITIS ULCERATIVE 3 0.0001
868 COLON CANCER 1 0.0001
869 BLOOD COUNT ABNORMAL 1 0.0001
870 PLEURAL EFFUSION 4 0.0001
871 SKIN IRRITATION 3 0.0001
872 NEPHROLITHIASIS 3 0.0001
873 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
874 DEVICE RELATED INFECTION 1 0.0001
875 EMOTIONAL DISORDER 2 0.0001
876 ANKLE FRACTURE 1 0.0001
877 DELUSION 1 0.0001
878 BONE DENSITY DECREASED 2 0.0001
879 PULMONARY EMBOLISM 6 0.0001
880 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
881 SEPSIS 7 0.0001
882 LACTIC ACIDOSIS 2 0.0001
883 HYPERTENSION 13 0.0001
884 CHOLELITHIASIS 2 0.0001
885 CARDIAC ARREST 5 0.0001
886 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
887 COAGULOPATHY 1 0.0001
888 NEOPLASM MALIGNANT 4 0.0001
889 RENAL IMPAIRMENT 5 0.0001
890 GASTRIC DISORDER 2 0.0001
891 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
892 DEVICE DEFECTIVE 1 0.0001
893 DEVICE USE ISSUE 1 0.0001
894 DRUG INTERACTION 9 0.0001
895 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
896 DRUG ERUPTION 1 0.0001
897 DEVICE ISSUE 5 0.0001
898 RESTLESSNESS 2 0.0001
899 CONJUNCTIVITIS 1 0.0001
900 BACTERIAL INFECTION 1 0.0001
901 DYSARTHRIA 2 0.0001
902 PNEUMONIA 17 0.0001
903 CHOLESTASIS 1 0.0001
904 DYSTONIA 1 0.0001
905 PLASMA CELL MYELOMA 2 0.0001
906 DISABILITY 1 0.0001
907 ABNORMAL BEHAVIOUR 2 0.0001
908 ABORTION SPONTANEOUS 2 0.0000
909 PROSTATE CANCER 4 0.0000
910 ILL-DEFINED DISORDER 3 0.0000
911 EXTRA DOSE ADMINISTERED 2 0.0000
912 PSORIATIC ARTHROPATHY 2 0.0000
913 BLINDNESS 2 0.0000
914 BODY TEMPERATURE INCREASED 1 0.0000
915 PSORIASIS 6 0.0000
916 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
917 ACUTE KIDNEY INJURY 7 0.0000
918 APPLICATION SITE PAIN 1 0.0000
919 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
920 NO ADVERSE EVENT 8 0.0000
921 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
922 ADVERSE EVENT 4 0.0000
923 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
924 CARDIAC DISORDER 4 0.0000
925 BLOOD GLUCOSE INCREASED 8 0.0000
926 COMA 2 0.0000
927 MULTIPLE SCLEROSIS 2 0.0000
928 MOBILITY DECREASED 3 0.0000
929 BLOOD GLUCOSE DECREASED 2 0.0000
930 ACNE 3 0.0000
931 CHRONIC KIDNEY DISEASE 3 0.0000
932 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
933 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
934 PANCREATITIS 2 0.0000
935 BREAST CANCER FEMALE 1 0.0000
936 CARDIAC FAILURE 3 0.0000
937 CARDIAC FAILURE CONGESTIVE 3 0.0000
938 DRUG EFFECT DECREASED 2 0.0000
939 PRODUCT QUALITY ISSUE 5 0.0000
940 NEUTROPENIA 5 0.0000
941 TREATMENT NONCOMPLIANCE 2 0.0000
942 HYPONATRAEMIA 2 0.0000
943 RHEUMATOID ARTHRITIS 4 0.0000
944 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
945 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
946 EMOTIONAL DISTRESS 4 0.0000
947 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
948 EXPOSURE DURING PREGNANCY 2 0.0000
949 DRUG-INDUCED LIVER INJURY 1 0.0000
950 FEBRILE NEUTROPENIA 2 0.0000
951 RENAL FAILURE 4 0.0000
952 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
953 DEVICE MALFUNCTION 2 0.0000
954 INJURY 2 0.0000
955 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
956 CEREBRAL HAEMORRHAGE 1 0.0000
957 C-REACTIVE PROTEIN INCREASED 1 0.0000
958 UNDERDOSE 2 0.0000
959 THROMBOCYTOPENIA 3 0.0000
960 HALLUCINATION 2 0.0000
961 COLITIS 1 0.0000
962 HOSPITALISATION 4 0.0000
963 DRUG DOSE OMISSION BY DEVICE 2 0.0000
964 DEVICE BREAKAGE 1 0.0000
965 TREATMENT FAILURE 2 0.0000
966 TOXICITY TO VARIOUS AGENTS 4 0.0000
967 CEREBROVASCULAR ACCIDENT 4 0.0000
968 DEATH 20 0.0000
969 OVERDOSE 5 0.0000
970 DEVICE LEAKAGE 1 0.0000
971 DEVICE DISLOCATION 1 0.0000
972 MYOCARDIAL INFARCTION 4 0.0000
973 PRODUCT STORAGE ERROR 2 0.0000
974 DRUG WITHDRAWAL SYNDROME 2 0.0000
975 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
976 BREAST CANCER 2 0.0000
977 ARRHYTHMIA 1 0.0000
978 HAEMORRHAGE 2 0.0000
979 DRUG DOSE OMISSION 3 0.0000
980 CONVULSION 1 0.0000
981 DEVICE EXPULSION 1 0.0000
982 DEEP VEIN THROMBOSIS 1 0.0000
983 DEVICE DIFFICULT TO USE 1 0.0000
984 DRUG ABUSE 1 0.0000
985 COMPLETED SUICIDE 1 0.0000
986 DRUG DEPENDENCE 1 0.0000